首页 | 本学科首页   官方微博 | 高级检索  
检索        

舒尼替尼诱导耐药鼻咽癌CNE2/DDP细胞表达NKG2DLs的机制
引用本文:黄宇贤,王 杨,李玉华,杨玉莲,赵同峰,何庆梅,卢惠芳,贺艳杰,黄 睿,郭坤元.舒尼替尼诱导耐药鼻咽癌CNE2/DDP细胞表达NKG2DLs的机制[J].中国肿瘤生物治疗杂志,2010,17(3):256-261.
作者姓名:黄宇贤  王 杨  李玉华  杨玉莲  赵同峰  何庆梅  卢惠芳  贺艳杰  黄 睿  郭坤元
作者单位:1. 南方医科大学,珠江医院,血液科,广东,广州,510282
2. 广东省人民医院,肺癌研究所,广东,广州,510080
基金项目:国家自然科学基金资助项目(No. 30973454);广东省自然科学基金重点项目(No. 9251051501000007)
摘    要:目的:初步探讨舒尼替尼诱导高、低表达ABCG2(ATPbinding cassette superfamily G member 2)分子的耐药鼻咽癌CNE2/DDP细胞(简称ABCG2highCNE2/DDP细胞、ABCG2lowCNE2/DDP细胞)中NKG2D配体(natural killer group 2 member D ligands,NKG2DLs)表达的分子机制。方法:Caspase8活化试剂盒和线粒体膜电位法分别检测NK细胞处理后ABCG2highCNE2/DDP细胞和ABCG2lowCNE2/DDP细胞caspase8活化水平和线粒体膜电位。RTPCR检测舒尼替尼处理前后两种CNE2/DDP细胞DNA损伤修复系统相关信号分子mRNA的表达。结果:CNE2/DDP细胞+NK细胞组中两种CNE2/DDP细胞caspase8活性均明显增强;舒尼替尼处理后的ABCG2low CNE2/DDP细胞+NK细胞组和ABCG2highCNE2/DDP细胞+NK细胞组中caspase8的活性是处理前的2~2.5倍(P<0.01)。舒尼替尼预处理后,CNE2/DDP细胞和NK细胞共培养体系中两种CNE2/DDP细胞的线粒体膜电位分别为(76.58±2.32)%和(73.11±1.93)%,较舒尼替尼处理前明显降低(P<0.05)。舒尼替尼可上调两种CNE2/DDP细胞中ATR、CHK1和CHK2 mRNA的表达,并诱导P53和NFκB mRNA的表达。结论:舒尼替尼可能通过激活DNA损伤修复系统相关信号分子和NFκB的表达,诱导耐药鼻咽癌CNE2/DDP细胞NKG2DLs的表达,同时经由死亡受体信号通路和线粒体信号通路增强NK细胞诱导的肿瘤细胞凋亡。

关 键 词:舒尼替尼  鼻咽肿瘤  NKG2D配体  自然杀伤细胞  DNA损伤
收稿时间:2009/12/12 0:00:00
修稿时间:2010/1/20 0:00:00

Mechanism of sunitinib inducing NKG2DLs expressions in multidrug resistant nasopharyngeal carcinoma CNE2/DDP cells
HUANG Yu-xian,WANG Yang,LI Yu-hu,YANG Yu-lian,ZHAO Tong-feng,HE Qing-mei,LU Hui-fang,HE Yan-Jie,HUANG Rui and GUO Kun-yuan.Mechanism of sunitinib inducing NKG2DLs expressions in multidrug resistant nasopharyngeal carcinoma CNE2/DDP cells[J].Chinese Journal of Cancer Biotherapy,2010,17(3):256-261.
Authors:HUANG Yu-xian  WANG Yang  LI Yu-hu  YANG Yu-lian  ZHAO Tong-feng  HE Qing-mei  LU Hui-fang  HE Yan-Jie  HUANG Rui and GUO Kun-yuan
Institution:Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China;Lung Cancer Institute, Guangdong General Hospital, Guangzhou 510080, Guangdong, China;Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China;Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China;Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China;Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China;Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China;Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China;Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China;Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong, China
Abstract:Objective To investigate the mechanism by which unitinib induces up-regulation of NKG2D ligands(NKG2DLs) expressions in nasopharyngeal carcinoma CNE2/DDP cells with high or low ABCG2 expression(ABCG2highCNE2/DDP cells or ABCG2lowCNE2/DDP cells).Methods: Caspase-8 activity and mitochondrial membrane potential were detected by caspase-8 activity kit and mitochondrial membrane potential assay kit in ABCG2highCNE2/DDP cells or ABCG2lowCNE2/DDP cells after co-cultured with NK cells.Expressions of signal molecule...
Keywords:sunitinib  nasopharyngeal neoplasms  natural killer groups 2 member D ligand(NKG2DL)  natural killer cell  DNA damage  
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号